Laboratory leaders should prepare now for the end of the federal public health emergency (PHE) for SARS-CoV-2. The White House announced the PHE would cease on May 11. One big change is that patients covered by Medicare, Medicaid, or private insurance may pay higher costs for COVID-19 treatment, including some diagnostic laboratory tests. If patients […]
February 13, 2023, Intelligence: Late-Breaking Lab News
- By Scott Wallask
- > From the Volume XXX No. 3 - February 13, 2023 Issue
- Tags: at-home diagnostic testing, Aurora Diagnostics, Centers for Medicare and Medicaid Services, CLIAC, Clinical Laboratory, CMS, COVID-19, cyberattack, Exact Sciences, Improvement Advisory Committee, in vitro diagnostics, IVD, Lisa Olson-Coombe, Medicaid, Medicare, myriad genetics, Pathology Inc., PHE, public health emergency, remote pathology, SARS-CoV-2, SIFIN, Sonic Healthcare USA, Tallahassee Memorial HealthCare, Vicki DiFrancesco
